Open Access

EMBO Molecular Medicine, volume 12, issue 4

Sepsis therapies: learning from 30 years of failure of translational research to propose new leads

JEAN-MARC CAVAILLON ¹

Mervyn Singer ²

Tomasz Skirecki ³

Show full list: 3 authors

Hide authors affiliations Show authors affiliations: 3 affiliations

Experimental Neuropathology Unit Institut Pasteur Paris France |

Bloomsbury Institute of Intensive Care Medicine University College London London UK |

Laboratory of Flow Cytometry and Department of Anesthesiology and Intensive Care Medicine Centre of Postgraduate Medical Education Warsaw Poland |

Publication type: Journal Article

Publication date: 2020-03-16

European Molecular Biology Organization

Journal: EMBO Molecular Medicine

scimago Q1

SJR: 3.964

CiteScore: 17.7

Impact factor: 9

ISSN: 17574676, 17574684

DOI: 10.15252/emmm.201810128

Copy DOI

Molecular Medicine

Found

Top-30

Journals

	2 4 6 8 10 12
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 11, 5.26% International Journal of Molecular Sciences 11 publications, 5.26%
Frontiers in Immunology	Frontiers in Immunology, 10, 4.78% Frontiers in Immunology 10 publications, 4.78%
Cells	Cells, 7, 3.35% Cells 7 publications, 3.35%
Journal of Clinical Medicine	Journal of Clinical Medicine, 4, 1.91% Journal of Clinical Medicine 4 publications, 1.91%
Frontiers in Pharmacology	Frontiers in Pharmacology, 4, 1.91% Frontiers in Pharmacology 4 publications, 1.91%
Frontiers in Medicine	Frontiers in Medicine, 4, 1.91% Frontiers in Medicine 4 publications, 1.91%
Scientific Reports	Scientific Reports, 4, 1.91% Scientific Reports 4 publications, 1.91%
Critical Care	Critical Care, 4, 1.91% Critical Care 4 publications, 1.91%
Intensive Care Medicine Experimental	Intensive Care Medicine Experimental, 3, 1.44% Intensive Care Medicine Experimental 3 publications, 1.44%
Nature Immunology	Nature Immunology, 3, 1.44% Nature Immunology 3 publications, 1.44%
Journal of Personalized Medicine	Journal of Personalized Medicine, 3, 1.44% Journal of Personalized Medicine 3 publications, 1.44%
Journal of Immunology	Journal of Immunology, 2, 0.96% Journal of Immunology 2 publications, 0.96%
Clinical Science	Clinical Science, 2, 0.96% Clinical Science 2 publications, 0.96%
Critical Care Explorations	Critical Care Explorations, 2, 0.96% Critical Care Explorations 2 publications, 0.96%
Pathogens	Pathogens, 2, 0.96% Pathogens 2 publications, 0.96%
Microorganisms	Microorganisms, 2, 0.96% Microorganisms 2 publications, 0.96%
Journal of Biomedical Science	Journal of Biomedical Science, 2, 0.96% Journal of Biomedical Science 2 publications, 0.96%
Immunity	Immunity, 2, 0.96% Immunity 2 publications, 0.96%
Cytokine	Cytokine, 2, 0.96% Cytokine 2 publications, 0.96%
Biochimica et Biophysica Acta - Molecular Basis of Disease	Biochimica et Biophysica Acta - Molecular Basis of Disease, 2, 0.96% Biochimica et Biophysica Acta - Molecular Basis of Disease 2 publications, 0.96%
PLoS ONE	PLoS ONE, 2, 0.96% PLoS ONE 2 publications, 0.96%
Journal of Intensive Medicine	Journal of Intensive Medicine, 2, 0.96% Journal of Intensive Medicine 2 publications, 0.96%
Advanced Functional Materials	Advanced Functional Materials, 2, 0.96% Advanced Functional Materials 2 publications, 0.96%
EMBO Molecular Medicine	EMBO Molecular Medicine, 2, 0.96% EMBO Molecular Medicine 2 publications, 0.96%
Biomarkers in Toxicology	Biomarkers in Toxicology, 2, 0.96% Biomarkers in Toxicology 2 publications, 0.96%
Biomedicine and Pharmacotherapy	Biomedicine and Pharmacotherapy, 2, 0.96% Biomedicine and Pharmacotherapy 2 publications, 0.96%
Cureus	Cureus, 2, 0.96% Cureus 2 publications, 0.96%
Current Opinion in Critical Care	Current Opinion in Critical Care, 2, 0.96% Current Opinion in Critical Care 2 publications, 0.96%
Experimental and Molecular Medicine	Experimental and Molecular Medicine, 1, 0.48% Experimental and Molecular Medicine 1 publication, 0.48%
	2 4 6 8 10 12

Publishers

	5 10 15 20 25 30 35 40
Springer Nature	Springer Nature, 38, 18.18% Springer Nature 38 publications, 18.18%
MDPI	MDPI, 35, 16.75% MDPI 35 publications, 16.75%
Elsevier	Elsevier, 35, 16.75% Elsevier 35 publications, 16.75%
Frontiers Media S.A.	Frontiers Media S.A., 20, 9.57% Frontiers Media S.A. 20 publications, 9.57%
Wiley	Wiley, 14, 6.7% Wiley 14 publications, 6.7%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 13, 6.22% Cold Spring Harbor Laboratory 13 publications, 6.22%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 8, 3.83% Ovid Technologies (Wolters Kluwer Health) 8 publications, 3.83%
Taylor & Francis	Taylor & Francis, 8, 3.83% Taylor & Francis 8 publications, 3.83%
Research Square Platform LLC	Research Square Platform LLC, 5, 2.39% Research Square Platform LLC 5 publications, 2.39%
Portland Press	Portland Press, 3, 1.44% Portland Press 3 publications, 1.44%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 3, 1.44% Public Library of Science (PLoS) 3 publications, 1.44%
Oxford University Press	Oxford University Press, 3, 1.44% Oxford University Press 3 publications, 1.44%
American Chemical Society (ACS)	American Chemical Society (ACS), 3, 1.44% American Chemical Society (ACS) 3 publications, 1.44%
The American Association of Immunologists	The American Association of Immunologists, 2, 0.96% The American Association of Immunologists 2 publications, 0.96%
Hindawi Limited	Hindawi Limited, 2, 0.96% Hindawi Limited 2 publications, 0.96%
BMJ	BMJ, 2, 0.96% BMJ 2 publications, 0.96%
Editions E D K	Editions E D K, 1, 0.48% Editions E D K 1 publication, 0.48%
Mary Ann Liebert	Mary Ann Liebert, 1, 0.48% Mary Ann Liebert 1 publication, 0.48%
European Molecular Biology Organization	European Molecular Biology Organization, 1, 0.48% European Molecular Biology Organization 1 publication, 0.48%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 1, 0.48% Royal Society of Chemistry (RSC) 1 publication, 0.48%
American Society for Clinical Investigation	American Society for Clinical Investigation, 1, 0.48% American Society for Clinical Investigation 1 publication, 0.48%
Rockefeller University Press	Rockefeller University Press, 1, 0.48% Rockefeller University Press 1 publication, 0.48%
Proceedings of the National Academy of Sciences (PNAS)	Proceedings of the National Academy of Sciences (PNAS), 1, 0.48% Proceedings of the National Academy of Sciences (PNAS) 1 publication, 0.48%
SAGE	SAGE, 1, 0.48% SAGE 1 publication, 0.48%
Japan Society for Clinical Anesthesia	Japan Society for Clinical Anesthesia, 1, 0.48% Japan Society for Clinical Anesthesia 1 publication, 0.48%
American Society for Microbiology	American Society for Microbiology, 1, 0.48% American Society for Microbiology 1 publication, 0.48%
American Association for the Advancement of Science (AAAS)	American Association for the Advancement of Science (AAAS), 1, 0.48% American Association for the Advancement of Science (AAAS) 1 publication, 0.48%
	5 10 15 20 25 30 35 40

We do not take into account publications without a DOI.
Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

28 Field Citation Ratio

11 Relative Citation Ratio

Cite this

GOST |

Cite this

GOST Copy

CAVAILLON J., Singer M., Skirecki T. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads // EMBO Molecular Medicine. 2020. Vol. 12. No. 4.

GOST all authors (up to 50) Copy

CAVAILLON J., Singer M., Skirecki T. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads // EMBO Molecular Medicine. 2020. Vol. 12. No. 4.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.15252/emmm.201810128

UR - https://doi.org/10.15252/emmm.201810128

TI - Sepsis therapies: learning from 30 years of failure of translational research to propose new leads

T2 - EMBO Molecular Medicine

AU - CAVAILLON, JEAN-MARC

AU - Singer, Mervyn

AU - Skirecki, Tomasz

PY - 2020

DA - 2020/03/16

PB - European Molecular Biology Organization

IS - 4

VL - 12

SN - 1757-4676

SN - 1757-4684

ER -

BibTex

Cite this

BibTex (up to 50 authors) Copy

@article{2020_CAVAILLON,

author = {JEAN-MARC CAVAILLON and Mervyn Singer and Tomasz Skirecki},

title = {Sepsis therapies: learning from 30 years of failure of translational research to propose new leads},

journal = {EMBO Molecular Medicine},

year = {2020},

volume = {12},

publisher = {European Molecular Biology Organization},

month = {mar},

url = {https://doi.org/10.15252/emmm.201810128},

number = {4},

doi = {10.15252/emmm.201810128}

}

Found error?

Message

Support chat

Publisher

European Molecular Biology Organization

Journal

EMBO Molecular Medicine

scimago Q1

SJR

3.964

CiteScore

17.7

Impact factor

ISSN

17574676 (Print)

17574684 (Electronic)